Humoral immunity in chronic allograft rejection: Puzzle pieces come together

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 101-106

  Thaunat, Olivier ^a,b,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

Author keywords

Accommodation; Antibody; B cell; Chronic antibody mediated rejection; Chronic rejection; Lymphoid neogenesis

Indexed keywords

ALLOANTIBODY; HLA ANTIGEN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CHRONIC GRAFT REJECTION; CHRONIC INFLAMMATION; GRAFT FAILURE; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMORAL IMMUNITY; KIDNEY TRANSPLANTATION; MICROVASCULATURE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNITY, HUMORAL; ISOANTIBODIES; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856551484     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.11.003     Document Type: Review

References (88)

1. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011, 11:450-462.
2. Lodhi S.A., Lamb K.E., Meier-Kriesche H.U. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011, 11:1226-1235.
3. Jeannet M., Pinn V.W., Flax M.H., Winn H.J., Russell P.S. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970, 282:111-117.
4. Shi C., Lee W.S., He Q., Zhang D., Fletcher D.L., Newell J.B., et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996, 93:4051-4056.
5. Thaunat O., Louedec L., Dai J., Bellier F., Groyer E., Delignat S., et al. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:2359-2365.
6. Russell P.S., Chase C.M., Colvin R.B. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997, 64:1531-1536.
7. Terasaki P.I., Ozawa M., Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7:408-415.
8. Smith R.N., Kawai T., Boskovic S., Nadazdin O., Sachs D.H., Cosimi A.B., et al. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am J Transplant 2006, 6:1790-1798.
9. Smith R.N., Kawai T., Boskovic S., Nadazdin O., Sachs D.H., Cosimi A.B., et al. Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant 2008, 8:1662-1672.
10. Steele D.J., Laufer T.M., Smiley S.T., Ando Y., Grusby M.J., Glimcher L.H., et al. Two levels of help for B cell alloantibody production. J Exp Med 1996, 183:699-703.
11. Vella J.P., Spadafora-Ferreira M., Murphy B., Alexander S.I., Harmon W., Carpenter C.B., et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 1997, 64:795-800.
12. Lakkis F.G., Arakelov A., Konieczny B.T., Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000, 6:686-688.
13. Einecke G., Sis B., Reeve J., Mengel M., Campbell P.M., Hidalgo L.G., et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009, 9:2520-2531.
14. Hidalgo L.G., Campbell P.M., Sis B., Einecke G., Mengel M., Chang J., et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009, 9:2532-2541.
15. Issa N., Cosio F.G., Gloor J.M., Sethi S., Dean P.G., Moore S.B., et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008, 86:681-685.
16. Loupy A., Hill G.S., Suberbielle-Boissel C., Anglicheau D., Zuber J., Timsit M.O., et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor specific antibodies (DSA). Am J Transplant 2011 Jan, 11(1):56-65.
17. Platt J.L. Antibodies in transplantation. Discov Med 2010, 10:125-133.
18. Parham P., McLean J. Characterization, evolution, and molecular basis of a polymorphic antigenic determinant shared by HLA-A and B products. Hum Immunol 1980, 1:131-139.
19. Duquesnoy R.J. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008, 20:594-601.
20. Thaunat O., Hanf W., Dubois V., McGregor B., Perrat G., Chauvet C., et al. Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. Transpl Immunol 2009, 20:209-211.
21. Collins Z.V., Arnold P.F., Peetoom F., Smith G.S., Walford R.L. A naturally occurring monospecific anti-HL-A8 isoantibody. Tissue Antigens 1973, 3:358-363.
22. Ravindranath M.H., Kaneku H., El-Awar N., Morales-Buenrostro L.E., Terasaki P.I. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera. J Immunol 2010, 185:1935-1948.
23. Zhang Q., Reed E.F. Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol 2010, 22:682-688.
24. Li L., Wadia P., Chen R., Kambham N., Naesens M., Sigdel T.K., et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A 2009, 106:4148-4153.
25. Fedoseyeva E.V., Kishimoto K., Rolls H.K., Illigens B.M., Dong V.M., Valujskikh A., et al. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002, 169:1168-1174.
26. Mascaro-Blanco A., Alvarez K., Yu X., Lindenfeld J., Olansky L., Lyons T., et al. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 2008, 41:442-453.
27. Miettinen A., Stow J.L., Mentone S., Farquhar M.G. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 1986, 163:1064-1084.
28. Reinsmoen N.L., Lai C.H., Heidecke H., Haas M., Cao K., Ong G., et al. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 2010, 90:1473-1477.
29. Heinemann F.M., Roth I., Rebmann V., Arnold M.L., Witzke O., Wilde B., et al. Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts. Hum Immunol 2007, 68:500-506.
30. Honger G., Hopfer H., Arnold M.L., Spriewald B.M., Schaub S., Amico P. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011, 92:41-47.
31. Wahrmann M., Exner M., Schillinger M., Haidbauer B., Regele H., Kormoczi G.F., et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006, 6:1033-1041.
32. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007, 25:21-50.
33. Yamada E., Tsukamoto Y., Sasaki R., Yagyu K., Takahashi N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J 1997, 14:401-405.
34. Raju T.S. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 2008, 20:471-478.
35. Mauiyyedi S., Pelle P.D., Saidman S., Collins A.B., Pascual M., Tolkoff-Rubin N.E., et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001, 12:574-582.
36. Regele H., Bohmig G.A., Habicht A., Gollowitzer D., Schillinger M., Rockenschaub S., et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002, 13:2371-2380.
37. Loupy A., Suberbielle-Boissel C., Hill G.S., Lefaucheur C., Anglicheau D., Zuber J., et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009, 9:2561-2570.
38. Martin L., Guignier F., Bocrie O., D'Athis P., Rageot D., Rifle G., et al. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy. Transplantation 2005, 79:1459-1461.
39. Rahimi S., Qian Z., Layton J., Fox-Talbot K., Baldwin W.M., Wasowska B.A. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004, 4:326-334.
40. Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., Williams W.W., Tolkoff-Rubin N., et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999, 10:2208-2214.
41. Feucht H.E., Schneeberger H., Hillebrand G., Burkhardt K., Weiss M., Riethmuller G., et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993, 43:1333-1338.
42. Sis B., Jhangri G.S., Bunnag S., Allanach K., Kaplan B., Halloran P.F. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009, 9:2312-2323.
43. Hirohashi T., Uehara S., Chase C.M., DellaPelle P., Madsen J.C., Russell P.S., et al. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010, 10:510-517.
44. Li F., Atz M.E., Reed E.F. Human leukocyte antigen antibodies in chronic transplant vasculopathy-mechanisms and pathways. Curr Opin Immunol 2009, 21:557-562.
45. Plissonnier D., Henaff M., Poncet P., Paris E., Tron F., Thuillez C., et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000, 69:2601-2608.
46. Zhang X., Rozengurt E., Reed E.F. HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration. Sci Signal 2010, 3:ra85.
47. Arosa F.A., Santos S.G., Powis S.J. Open conformers: the hidden face of MHC-I molecules. Trends Immunol 2007, 28:115-123.
48. Platt J.L., Vercellotti G.M., Dalmasso A.P., Matas A.J., Bolman R.M., Najarian J.S., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990, 11:450-456. discussion 6-7.
49. Bannett A.D., McAlack R.F., Morris M., Chopek M.W., Platt J.L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplantation. Transplant Proc 1989, 21:783-785.
50. Dalmasso A.P., Benson B.A., Johnson J.S., Lancto C., Abrahamsen M.S. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000, 164:3764-3773.
51. Hourmant M., Cesbron-Gautier A., Terasaki P.I., Mizutani K., Moreau A., Meurette A., et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005, 16:2804-2812.
52. Platt J.L., Nath K.A. Heme oxygenase: protective gene or Trojan horse. Nat Med 1998, 4:1364-1365.
53. Tang A.H., Platt J.L. Accommodation of grafts: implications for health and disease. Hum Immunol 2007, 68:645-651.
54. Kohler H., Paul S. Superantibody activities: new players in innate and adaptive immune responses. Immunol Today 1998, 19:221-227.
55. Tramontano A., Janda K.D., Lerner R.A. Catalytic antibodies. Science 1986, 234:1566-1570. New York, NY.
56. Lacroix-Desmazes S., Bayry J., Kaveri S.V., Hayon-Sonsino D., Thorenoor N., Charpentier J., et al. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A 2005, 102:4109-4113.
57. Holschermann H., Bohle R.M., Zeller H., Schmidt H., Stahl U., Fink L., et al. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol 1999, 154:211-220.
58. Wootla B., Nicoletti A., Patey N., Dimitrov J.D., Legendre C., Christophe O.D., et al. Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients. J Immunol 2008, 180:8455-8460.
59. Batista F.D., Iber D., Neuberger M.S. B cells acquire antigen from target cells after synapse formation. Nature 2001, 411:489-494.
60. Tarlinton D.M., Batista F., Smith K.G. The B-cell response to protein antigens in immunity and transplantation. Transplantation 2008, 85:1698-1704.
61. Linton P.J., Harbertson J., Bradley L.M. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000, 165:5558-5565.
62. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138.
63. Zarkhin V., Kambham N., Li L., Kwok S., Hsieh S.C., Salvatierra O., et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008, 74:664-673.
64. Baddoura F.K., Nasr I.W., Wrobel B., Li Q., Ruddle N.H., Lakkis F.G. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. Am J Transplant 2005, 5:510-516.
65. Kerjaschki D., Regele H.M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004, 15:603-612.
66. Thaunat O., Field A.C., Dai J., Louedec L., Patey N., Bloch M.F., et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A 2005, 102:14723-14728.
67. Thaunat O., Nicoletti A. Lymphoid neogenesis in chronic rejection. Curr Opin Organ Transplant 2008, 13:16-19.
68. Thaunat O. Pathophysiologic significance of B-cell clusters in chronically rejected grafts. Transplantation 2011, 92:121-126.
69. Thaunat O., Patey N., Caligiuri G., Gautreau C., Mamani-Matsuda M., Mekki Y., et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 2010, 185:717-728.
70. Deteix C., Attuil-Audenis V., Duthey A., Patey N., McGregor B., Dubois V., et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 2010, 184:5344-5351.
71. Thaunat O., Graff-Dubois S., Fabien N., Duthey A., Attuil-Audenis V., Nicoletti A., et al. A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection. Kidney Int 2011 Sept 21, doi:10.1038/ki.2011.317.
72. Thaunat O., Patey N., Gautreau C., Lechaton S., Fremeaux-Bacchi V., Dieu-Nosjean M.C., et al. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. Transplantation 2008, 85:1648-1653.
73. Thaunat O., Kerjaschki D., Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis?. Trends Immunol 2006, 27:441-445.
74. Thaunat O., Graff-Dubois S., Brouard S., Gautreau C., Varthaman A., Fabien N., et al. Immune responses elicited in tertiary lymphoid tissues display distinctive features. PLoS One 2010, 5:e11398.
75. Motallebzadeh R., Rehakova S., Conlon T.M., Win T.S., Callaghan C.J., Goddard M., et al. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J 2011.
76. Brown K., Sacks S.H., Wong W. Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Eur J Immunol 2011, 41:89-96.
77. Le Texier L., Thebault P., Lavault A., Usal C., Merieau E., Quillard T., et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011, 11:429-438.
78. Shimamura T., Hashimoto K., Sasaki S. Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells. Cell Immunol 1982, 68:104-113.
79. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
80. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430.
81. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501.
82. Thaunat O., Morelon E., Defrance T. Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis. Blood 2010, 116:515-521.
83. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007, 178:6092-6099.
84. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
85. Clatworthy M.R., Watson C.J., Plotnek G., Bardsley V., Chaudhry A.N., Bradley J.A., et al. B-cell-depleting induction therapy and acute cellular rejection. N Engl J Med 2009, 360:2683-2685.
86. Newell K.A., Asare A., Kirk A.D., Gisler T.D., Bourcier K., Suthanthiran M., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836-1847.
87. Pallier A., Hillion S., Danger R., Giral M., Racape M., Degauque N., et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010, 78:503-513.
88. Sagoo P., Perucha E., Sawitzki B., Tomiuk S., Stephens D.A., Miqueu P., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120:1848-1861.